益升医学 (870450.OC)

+ 收藏

财务摘要(报告期)(益升医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.070.260.04-0.20-
 每股收益 - 稀释(元) 0.070.260.04-0.20-
 每股收益 - 期末股本摊薄(元) 0.070.260.04-0.20-
 每股净资产BPS(元) 0.890.830.610.570.78
 每股经营活动产生的现金流量净额(元) -0.220.220.330.14-0.08
 每股营业收入(元) 1.151.980.661.530.40
关键比率:
 净资产收益率 - 摊薄(%) 7.4231.477.13-35.57-0.36
 净资产收益率 - 加权(%) 7.7028.967.17-30.20-0.35
 净资产收益率 - 平均(%) 7.7037.347.39-30.20-0.36
 净资产收益率 - 扣除(%) 6.9623.02-4.42-48.84-0.36
 总资产净利率 - 平均(%) 2.9612.862.80-10.55-0.13
 总资产报酬率ROA(%) 3.2213.743.39-9.160.36
 投入资本回报率ROIC(%) 5.2722.825.03-13.860.56
 销售毛利率(%) 50.1868.7675.9451.5271.50
 销售净利率(%) 5.6913.076.48-13.21-0.77
 资产负债率(%) 50.2867.6762.1759.6964.84
 资产周转率(倍) 0.520.980.430.800.17
 销售商品提供劳务收到的现金/营业收入(%) 69.56149.14195.79100.34158.61
 营业利润同比增长率(%) 39.67229.521,317.084.2393.31
 营业收入同比增长率(%) 72.7229.5766.26-43.92-69.68
 利润总额同比增长率(%) 51.57229.021,506.504.8194.40
 归属母公司股东的净利润同比增长率(%) 52.28229.101,689.17-17.8594.85
 扣非后归属母公司股东的净利润同比增长率(%) 330.65168.78-884.03-63.1594.85
 总资产同比增长率(%) 10.4880.45-25.68-39.96-15.59
 总负债同比增长率(%) -10.65104.58-28.74-46.790.81
 净资产同比增长率(%) 46.3745.92-20.29-26.24-34.60
利润表摘要:
 营业总收入(元) 22,954,915.1839,621,277.6313,290,583.7930,578,520.397,993,693.99
 营业总成本(元) 21,731,324.1035,819,287.2413,834,962.1536,103,298.078,065,674.71
 营业收入(元) 22,954,915.1839,621,277.6313,290,583.7930,578,520.397,993,693.99
 营业利润(元) 1,223,591.085,209,469.89876,063.16-4,022,080.26-71,980.72
 利润总额(元) 1,305,732.005,191,922.39861,487.58-4,024,177.64-61,250.57
 净利润(元) 1,305,732.005,178,390.98861,487.58-4,038,305.30-61,250.57
 归属母公司股东的净利润(元) 1,322,183.675,192,177.49868,244.29-4,021,966.16-54,634.94
 非经常性损益(元) 82,140.921,393,907.001,405,865.941,500,600.0410,730.15
 归属母公司股东的净利润扣除非经常性损益(元) 1,240,042.753,798,270.49-537,621.65-5,522,566.20-54,634.94
资产负债表摘要:
 流动资产(元) 21,569,063.2535,449,172.5214,793,416.898,229,897.7221,046,489.50
 固定资产(元) 12,731,987.6414,298,084.3615,886,375.0218,287,871.3620,873,271.72
 资产总计(元) 36,333,311.9951,833,359.3432,887,108.4628,725,085.6344,248,888.11
 流动负债(元) 18,268,843.4535,074,622.8020,445,533.9917,144,740.0728,691,488.86
 负债合计(元) 18,268,843.4535,074,622.8020,445,533.9917,144,740.0728,691,488.86
 股东权益(元) 18,064,468.5416,758,736.5412,441,574.4711,580,345.5615,557,399.25
 归属母公司股东的权益(元) 17,822,379.9816,500,196.3112,176,263.1111,308,018.8315,275,350.05
 资本公积(元) 960,243.95960,243.95960,243.95960,243.95960,243.95
 盈余公积(元) 1,212,861.391,212,861.39689,507.69689,507.69689,507.69
 未分配利润(元) -4,350,725.36-5,672,909.03-9,473,488.53-10,341,732.81-6,374,401.59
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 15,968,480.4559,090,583.4126,021,293.7730,681,945.5212,678,526.84
 经营活动产生的现金净流量(元) -4,374,354.364,314,877.576,652,819.492,798,252.84-1,623,175.35
 投资活动产生的现金净流量(元) -1,411,454.50-1,502,697.42-
 取得借款收到的现金(元) 2,500,000.0024,819,200.006,416,000.0016,144,500.006,300,000.00
 筹资活动产生的现金净流量(元) -1,114,123.61-2,000,236.01-2,757,436.97-4,176,176.27465,480.57
 现金及现金等价物净增加(元) -5,488,477.973,726,096.063,895,382.52124,773.99-1,157,694.78
 期末现金及现金等价物余额(元) 272,518.215,760,996.185,930,282.642,034,900.12752,424.88
 折旧与摊销(元) 1,566,096.72-1,621,767.743,339,529.281,681,921.92
公告日期 2024-08-202024-04-252023-08-172023-04-262022-08-18
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院